Figure 2. Reactogenicity Rates Following BNT162b2 Vaccine by Symptom Severity.
Localized and systemic symptoms that occurred after the first (A) and second (B) doses of the vaccine.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.